Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Urology"

189 News Found

AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment
Medical Device | June 19, 2026

AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment

Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)


Biopharma industry confidence reaches four-year high: GlobalData survey
Biopharma | June 19, 2026

Biopharma industry confidence reaches four-year high: GlobalData survey

Findings show growing optimism across the pharma sector as dealmaking accelerates, innovation strengthens, and companies adapt to tariffs, pricing reforms, and looming patent expirations


Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
People | June 13, 2026

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor

Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders


Roche signs up to $2.3 billion deal with Nurix for BTK degrader Bexobrutideg
News | June 08, 2026

Roche signs up to $2.3 billion deal with Nurix for BTK degrader Bexobrutideg

The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases


Hinduja Hospital and Dr. Homi Bhabha State University to conduct PG allied health courses
Hospitals | June 08, 2026

Hinduja Hospital and Dr. Homi Bhabha State University to conduct PG allied health courses

The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course


Peer-led mental health intervention improves transgender well-being: Study
Healthcare | June 04, 2026

Peer-led mental health intervention improves transgender well-being: Study

A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies


Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal
News | June 03, 2026

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal

The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments


CORONA Remedies receives EU-GMP certification for hormone facility
News | June 02, 2026

CORONA Remedies receives EU-GMP certification for hormone facility

Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets


proRITHM ranked among top healthcare innovations in Andhra Pradesh
Medical Device | June 01, 2026

proRITHM ranked among top healthcare innovations in Andhra Pradesh

AI-enabled wearable remote patient monitoring platform successfully completed pilot deployments in a government super-specialty hospital and emergency ambulances


Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System
Medical Device | May 26, 2026

Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System

Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery